Longaeva Partners’s Hinge Health HNGE Stock Holding History

Longaeva Partners’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45,813	Closed	-$2.37M	–	95
2025 Q2	$2.37M	Buy	+45,813	New	+$1.85M	0.48%	32

Other funds holding HNGE

IHG

Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Longaeva Partners's HNGE Position: Q3 2025 in Review

Longaeva Partners sold out of Hinge Health (HNGE) in Q3 2025, closing a stake of 45,813 shares — an estimated $2.37M sold.

Longaeva Partners first reported a position in HNGE in Q2 2025 and held it in 1 quarter. The position peaked at $2.37M in Q2 2025. 146 funds tracked by Wall St. Rank hold HNGE as of Q3 2025.

Longaeva Partners reported no remaining Hinge Health position as of Q3 2025 after selling out during the quarter.
Longaeva Partners sold 45,813 Hinge Health shares in Q3 2025, an estimated $2.37M.
Longaeva Partners first reported a position in Hinge Health in Q2 2025 and held it in 1 quarter.
Longaeva Partners's Hinge Health position peaked at $2.37M in Q2 2025.
146 funds tracked by Wall St. Rank held Hinge Health as of Q3 2025.

Based on Longaeva Partners's 13F filing for Q3 2025, filed 14 Nov 2025.